CytomX Therapeutics Inc (CTMX)
1.59
-0.01
(-0.62%)
USD |
NASDAQ |
Apr 26, 16:00
1.60
+0.01
(+0.63%)
After-Hours: 20:00
CytomX Therapeutics Cash from Investing (TTM): -150.67M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -150.67M |
| September 30, 2023 | -63.72M |
| June 30, 2023 | -21.19M |
| March 31, 2023 | -47.65M |
| December 31, 2022 | 98.26M |
| September 30, 2022 | -1.803M |
| June 30, 2022 | 8.341M |
| March 31, 2022 | -37.26M |
| December 31, 2021 | 22.49M |
| September 30, 2021 | 42.19M |
| June 30, 2021 | -57.61M |
| March 31, 2021 | 37.85M |
| December 31, 2020 | -18.72M |
| September 30, 2020 | 14.68M |
| June 30, 2020 | 143.26M |
| March 31, 2020 | 100.75M |
| December 31, 2019 | 79.70M |
| Date | Value |
|---|---|
| September 30, 2019 | 42.69M |
| June 30, 2019 | 0.996M |
| March 31, 2019 | 10.70M |
| December 31, 2018 | 5.926M |
| September 30, 2018 | -159.67M |
| June 30, 2018 | -140.55M |
| March 31, 2018 | -143.86M |
| December 31, 2017 | -121.27M |
| September 30, 2017 | 70.94M |
| June 30, 2017 | 66.31M |
| March 31, 2017 | 31.49M |
| December 31, 2016 | 45.86M |
| September 30, 2016 | -47.44M |
| June 30, 2016 | -57.45M |
| March 31, 2016 | -64.94M |
| December 31, 2015 | -130.56M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-150.67M
Minimum
Dec 2023
143.26M
Maximum
Jun 2020
10.14M
Average
8.341M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
| Ocular Therapeutix Inc | -6.087M |
| Bristol-Myers Squibb Co | -21.70B |
| ACADIA Pharmaceuticals Inc | 32.00M |
| Cytokinetics Inc | 239.25M |
| Calidi Biotherapeutics Inc | -- |